General anesthetic is one of 172 small molecule programs targeting Neurotoxicity. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
88 competitors in Cognition
Revia
Pitocin
Accutane
Xarelto
Namenda
Fintepla
Epidiolex
Nuplazid
Remimazolam Tosilate
Psilocybin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details